NDC 58468-0070-01 - ALDURAZYME
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58468-0070
- Requested NDC
- 58468-0070-01
- Package NDCs from labels
- 58468-0070-1, 58468-0070-01
- Manufacturer
- Genzyme Corporation
- Effective date
- 2026-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALDURAZYME - Genzyme Corporation | Genzyme Corporation | 2026-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58468-0070-1 | ALDURAZYME | 5 mL in 1 VIAL, GLASS | INJECTION, SOLUTION, CONCENTRATE | 5 | 37 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58468-0070 | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 36 | Current NDC, Legacy NDC, 1 package rows | 20241010_a80ac249-cae4-41f3-88bb-344088b20e60.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58468-0070-1 | ML - Milliliter | 58468-0070 | badfca37-3948-4cd6-a8de-04dfd0679aab | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LARONIDASE | ACTIVE INGREDIENT | WP58SVM6R4 | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| LARONIDASE | ACTIVE MOIETY | WP58SVM6R4 | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INACTIVE INGREDIENT | 70WT22SF4B | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | ALDURAZYME (LARONIDASE) INJECTION, SOLUTION, CONCENTRATE [GENZYME CORPORATION] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALDURAZYME | LARONIDASE | Genzyme Corporation | a80ac249-cae4-41f3-88bb-344088b20e60 | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | BLA125058 58468-0070-1 58468-0070 58468007001 403822 404492 c37ec1bf-5497-45ca-a204-915b91bff0f6 a80ac249-cae4-41f3-88bb-344088b20e60 WP58SVM6R4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.